The emerging role of histologic disease activity assessment in ulcerative colitis
Author:
Funder
Seres Therapeutics
Eli Lilly
Genentech
AbbVie
Sandoz
Takeda
Janssen
Robarts Clinical Trials
GlaxoSmithKline
ARENA
Topivert
Publisher
Elsevier BV
Subject
Gastroenterology,Radiology Nuclear Medicine and imaging
Reference54 articles.
1. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies;Frolkis;Gastroenterology,2013
2. US Department of Health and Human Services. Ulcerative Colitis: Clinical Trial Endpoints Guidance for Industry. Available at: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM515143.pdf. Accessed March 17, 2018.
3. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015
4. Are endoscopic endpoints reliable in therapeutic trials of ulcerative colitis?;Wolff;Inflamm Bowel Dis,2013
5. Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission;Feagins;Inflamm Bowel Dis,2013
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hypersampsonone H attenuates ulcerative colitis via inhibition of PDE4 and regulation of cAMP/PKA/CREB signaling pathway;International Immunopharmacology;2024-02
2. Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity;The Korean Journal of Internal Medicine;2024-01-01
3. Studies on the mechanism of local and extra-intestinal tissue manifestations in AOM-DSS-induced carcinogenesis in BALB/c mice: role of PARP-1, NLRP3, and autophagy;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-13
4. Artificial Intelligence in IBD: How Will It Change Patient Management?;Current Treatment Options in Gastroenterology;2023-12-01
5. Concept «grade-stage» in morphological diagnostics of chronic colitis in inflammatory bowel disease;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2023-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3